Matches in Nanopublications for { ?s ?p "[Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962639.RAeRwnoOyN4Rj1bRocfeKNynoWt4N-q5BIfHPCipIxXR4130_assertion description "[Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962639.RAeRwnoOyN4Rj1bRocfeKNynoWt4N-q5BIfHPCipIxXR4130_provenance.
- assertion description "[Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP542707.RAkq9KgesfilAolyOf6xyaMVrxRFty5WzBX211PTswXVU130_assertion description "[Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542707.RAkq9KgesfilAolyOf6xyaMVrxRFty5WzBX211PTswXVU130_provenance.
- NP542829.RAC0Q2O7MW8XWW6eSIpqBIZRevtnJlfYLOIqtmfxH5iJ4130_assertion description "[Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542829.RAC0Q2O7MW8XWW6eSIpqBIZRevtnJlfYLOIqtmfxH5iJ4130_provenance.
- assertion description "[Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_assertion description "[Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.